Music |
Video |
Movies |
Chart |
Show |
Emmaus Life Sciences progressing with expanding availability of lead drug Endari internationally (Proactive Investors) View | |
Emmaus Life Sciences makes progress in advancing Endari as it reports 2021 revenue of $20.6M (Proactive Investors) View | |
Emmaus Life Sciences launches full-service telehealth solution with online access to Endari (Proactive Investors) View | |
6 Minute CEO - Yutaka Niihara - Treatment for Sickle Cell Disease (O\u0026M Partners) View | |
FDA-Approved Sickle Cell Treatment for Children Five Years and Older (HPR) View | |
Canopy Rivers Inc (CVE:RIV) Horizontally Integrated Investment Ecosystem (Midas Letter) View | |
The Kaival Brands Story (Kaival Brands) View | |
() View | |
() View | |
() View |